---
figid: PMC6335777__APS2019-7943481.002
figlink: /pmc/articles/PMC6335777/figure/fig2/
number: Figure 2
caption: Effects of ketamine on the glutamatergic synapse. Ketamine acts as an NMDA
  antagonist on GABAergic interneurons, as well as on postsynaptic glutamatergic neurons.
  Antagonism in the former results in disinhibition of presynaptic glutamatergic neurons,
  thus favoring activation of AMPAR in postsynaptic glutamatergic neurons. This, along
  with activation of voltage-dependent calcium channels, results in activation of
  the PI3K pathway which leads to increased mTOR activity. Furthermore, antagonism
  of NMDAR leads to inhibition of the nitric oxide pathway, which in turn leads to
  Rheb stabilization and mTOR pathway potentiation. mTOR increases p70s6K activity,
  which promotes BDNF signaling. BDNF activity is also favored by the inactivation
  of eEf2K secondary to NMDAR antagonism.
pmcid: PMC6335777
papertitle: 'Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological
  Approaches beyond Monoamines.'
reftext: Mervin Ch√°vez-Castillo, et al. Adv Pharmacol Sci. 2019;2019:7943481.
pmc_ranked_result_index: '75980'
pathway_score: 0.9349146
filename: APS2019-7943481.002.jpg
figtitle: Ketamine on the glutamatergic synapse
year: '2019'
organisms: Homo sapiens
ndex: d00173ff-df08-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6335777__APS2019-7943481.002.html
  '@type': Dataset
  description: Effects of ketamine on the glutamatergic synapse. Ketamine acts as
    an NMDA antagonist on GABAergic interneurons, as well as on postsynaptic glutamatergic
    neurons. Antagonism in the former results in disinhibition of presynaptic glutamatergic
    neurons, thus favoring activation of AMPAR in postsynaptic glutamatergic neurons.
    This, along with activation of voltage-dependent calcium channels, results in
    activation of the PI3K pathway which leads to increased mTOR activity. Furthermore,
    antagonism of NMDAR leads to inhibition of the nitric oxide pathway, which in
    turn leads to Rheb stabilization and mTOR pathway potentiation. mTOR increases
    p70s6K activity, which promotes BDNF signaling. BDNF activity is also favored
    by the inactivation of eEf2K secondary to NMDAR antagonism.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GAPDH
  - MTOR
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - GRIN1
  - EEF2K
  - PIK3R5
  - PIK3R4
  - GRIN2A
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3CA
  - GRIN3A
  - GRIN3B
  - NOS1
  - PIK3R3
  - AKT2
  - BDNF
  - PIK3R6
  - AKT3
  - AKT1
  - RHEB
  - RPS6KB2
  - RPS6KB1
  - Glutamate
  - Ketamine
  - Na
genes:
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: EEF2K
  symbol: EEF2K
  source: hgnc_symbol
  hgnc_symbol: EEF2K
  entrez: '29904'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: NNOS
  symbol: nNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB2
  entrez: '6199'
- word: P70S6K
  symbol: P70S6K
  source: bioentities_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
chemicals:
- word: Glutamate
  source: ''
  identifier: ''
- word: Ketamine
  source: MESH
  identifier: D007649
- word: Na
  source: MESH
  identifier: D012964
diseases: []
---
